Some patients with diabetes develop a serious condition known as diabetic cardiomyopathy, which is slow and cannot be directly attributed to hypertension or other cardiovascular disorders.

Some patients with diabetes develop a serious condition known as diabetic cardiomyopathy, which proceeds slowly and cannot be directly attributed to hypertension or other cardiovascular disorders.

Some patients with diabetes develop a serious condition known as diabetic cardiomyopathy, which is slow and cannot be directly attributed to hypertension or other cardiovascular disorders.This ...

Dilated cardiomyopathy (DCM) is a heterogeneous disorder that is familial in approximately 30% of cases. Although several genes have been identified that can cause familial DCM, molecular analyses ...

Caficrestat is under clinical development by Applied Therapeutics and currently in Phase III for Diabetic Peripheral Neuropathy.

Monash University drug discovery researchers have found that a natural fat molecule called ‘lipoxin A4’ (LXA4) could significantly reduce inflammation and improve function for diabetic hearts ...

The US Food and Drug Administration declined to approve the drug for people with type 1 diabetes and chronic kidney disease.

Imeglimin (Twymeeg) is an antidiabetic agent. It is formulated as film coated tablets for oral route of administration. Twymeeg is indicated for the treatment of type 2 diabetes.